FDA Inspection
ImpactLifeImpactLife – FDA Inspection, May 9, 2025
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on May 9, 2025, issued by the Minneapolis District Office, covering biologics.
View Company Profile
ID · 7e234f5c-6535-4a46-8d14-6bbcd2d0d2ba
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1269513
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ImpactLife
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 20, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1147979 - 2021-07-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.